Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.
Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, Hammer GD. Heaton JH, et al. Among authors: lerario am. Am J Pathol. 2012 Sep;181(3):1017-33. doi: 10.1016/j.ajpath.2012.05.026. Epub 2012 Jul 15. Am J Pathol. 2012. PMID: 22800756 Free PMC article.
Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ, Soares IC, Ribeiro TC, Fragoso MC, Marins LV, Wakamatsu A, Ressio RA, Nishi MY, Jorge AA, Lerario AM, Alves VA, Mendonca BB, Latronico AC. Almeida MQ, et al. Among authors: lerario am. J Clin Endocrinol Metab. 2010 Mar;95(3):1458-62. doi: 10.1210/jc.2009-2040. Epub 2010 Jan 15. J Clin Endocrinol Metab. 2010. PMID: 20080844
Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor.
Lima Lde O, Lerario AM, Alencar GA, Brito LP, Almeida MQ, Domenice S, Latronico AC, Mendonca BB, Fragoso MC. Lima Lde O, et al. Among authors: lerario am. Arq Bras Endocrinol Metabol. 2011 Feb;55(1):72-7. doi: 10.1590/s0004-27302011000100010. Arq Bras Endocrinol Metabol. 2011. PMID: 21468523
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients.
Fragoso MC, Almeida MQ, Mazzuco TL, Mariani BM, Brito LP, Gonçalves TC, Alencar GA, Lima Lde O, Faria AM, Bourdeau I, Lucon AM, Freire DS, Latronico AC, Mendonca BB, Lacroix A, Lerario AM. Fragoso MC, et al. Among authors: lerario am. Eur J Endocrinol. 2012 Jan;166(1):61-7. doi: 10.1530/EJE-11-0806. Epub 2011 Nov 2. Eur J Endocrinol. 2012. PMID: 22048964
Genetics and epigenetics of adrenocortical tumors.
Lerario AM, Moraitis A, Hammer GD. Lerario AM, et al. Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9. Mol Cell Endocrinol. 2014. PMID: 24220673 Free PMC article. Review.
The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial.
Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD. Lerario AM, et al. Horm Cancer. 2014 Aug;5(4):232-9. doi: 10.1007/s12672-014-0182-1. Epub 2014 May 22. Horm Cancer. 2014. PMID: 24849545 Free PMC article. Clinical Trial.
133 results